No description available.

High chronic fructose consumption is linked to a nonalcoholic steatohepatitis (NASH) type of hepatotoxicity. Oxalate is the major endpoint of fructose metabolism, which accumulates in the kidney causing renal stone disease. Both diseases are life-threatening if not treated. Our objective was to study the molecular cytotoxicity mechanisms of fructose and some of its metabolites in the liver. Fructose metabolites were incubated with primary rat hepatocytes, but cytotoxicity only occurred if the hepatocytes were exposed to non-toxic amounts of hydrogen peroxide such as those released by activated immune cells. Glyoxal was most likely the endogenous toxin responsible for fructose induced toxicity formed via autoxidation of the fructose metabolite glycolaldehyde catalyzed by superoxide radicals, or oxidation by Fenton’s hydroxyl radicals. As for hyperoxaluria, glyoxylate was more cytotoxic than oxalate presumably because of the formation of condensation product oxalomalate causing mitochondrial toxicity and oxidative stress. Oxalate toxicity likely involved pro-oxidant iron complex formation.

High chronic fructose consumption is linked to a nonalcoholic steatohepatitis (NASH) type of hepatotoxicity. Oxalate is the major endpoint of fructose metabolism, which accumulates in the kidney causing renal stone disease. Both diseases are life-threatening if not treated. Our objective was to study the molecular cytotoxicity mechanisms of fructose and some of its metabolites in the liver. Fructose metabolites were incubated with primary rat hepatocytes, but cytotoxicity only occurred if the hepatocytes were exposed to non-toxic amounts of hydrogen peroxide such as those released by activated immune cells. Glyoxal was most likely the endogenous toxin responsible for fructose induced toxicity formed via autoxidation of the fructose metabolite glycolaldehyde catalyzed by superoxide radicals, or oxidation by Fenton’s hydroxyl radicals. As for hyperoxaluria, glyoxylate was more cytotoxic than oxalate presumably because of the formation of condensation product oxalomalate causing mitochondrial toxicity and oxidative stress. Oxalate toxicity likely involved pro-oxidant iron complex formation.

It has been suggested for many decades that the essential and ubiquitous enzyme fructose 1,6-bisphosphate aldolase (FBA) could be a good drug target against bacteria and fungi, since lower organisms possess a metal-dependent (Class II) FBA, as opposed to higher organisms which possess a Schiff-base forming, metal-independent (Class I) FBA. The purpose of this doctoral project was to purify and study the inhibition of Class II FBA from pathogenic organisms. The capacity of various thiol compounds, as well as various derivatives of the metal-chelating compound dipicolinic acid, to inhibit the purified Class II FBAs from Mycobacterium tuberculosis, Pseudomonas aeruginosa, Bacillus cereus, and Magnaporthe grisea, was compared. The genes were subcloned in the Escherichia coli vector pT7-7 and the enzymes purified to near homogeneity, and characterized using a coupled assay. A small fed-batch fermentor was used to express the enzymes in E. coli, and yields of up to 2 grams of purified protein per liter of bacterial culture were obtained. The commercially available compound 2,3-dimercaptopropane sulfonate was found to be the most effective inhibitor against the aldolase from M. tuberculosis, with a second order binding rate constant of 500 +/- 4 M-1 s-1, which is three times and twenty times higher than the constants obtained with dipicolinic acid and EDTA, respectively. In an attempt to detect the enzyme dynamics during catalysis or inhibition, tryptophan residues were used as reporter groups and introduced by site-directed mutagenesis into the catalytic mobile loops and near the active site of the aldolases from M. tuberculosis, P. aeruginosa and B. cereus. The kinetic characterization of the mutants is described; as well as the effect of substrate binding on the steady-state and time-resolved fluorescence signals. Finally, the possibility of using the recombinant Class II FBP aldolases for industrial chemical synthesis was explored by measuring the enzymatic stability in organic solvents, at high temperatures and at different pH conditions. Surprisingly, the commercial Class I enzyme from rabbit muscle was more stable than the metalloenzymes in most conditions tested. The results presented in this thesis will be useful for the future design of Class II FBP aldolase inhibitors.

It has been suggested for many decades that the essential and ubiquitous enzyme fructose 1,6-bisphosphate aldolase (FBA) could be a good drug target against bacteria and fungi, since lower organisms possess a metal-dependent (Class II) FBA, as opposed to higher organisms which possess a Schiff-base forming, metal-independent (Class I) FBA. The purpose of this doctoral project was to purify and study the inhibition of Class II FBA from pathogenic organisms. The capacity of various thiol compounds, as well as various derivatives of the metal-chelating compound dipicolinic acid, to inhibit the purified Class II FBAs from Mycobacterium tuberculosis, Pseudomonas aeruginosa, Bacillus cereus, and Magnaporthe grisea, was compared. The genes were subcloned in the Escherichia coli vector pT7-7 and the enzymes purified to near homogeneity, and characterized using a coupled assay. A small fed-batch fermentor was used to express the enzymes in E. coli, and yields of up to 2 grams of purified protein per liter of bacterial culture were obtained. The commercially available compound 2,3-dimercaptopropane sulfonate was found to be the most effective inhibitor against the aldolase from M. tuberculosis, with a second order binding rate constant of 500 +/- 4 M-1 s-1, which is three times and twenty times higher than the constants obtained with dipicolinic acid and EDTA, respectively. In an attempt to detect the enzyme dynamics during catalysis or inhibition, tryptophan residues were used as reporter groups and introduced by site-directed mutagenesis into the catalytic mobile loops and near the active site of the aldolases from M. tuberculosis, P. aeruginosa and B. cereus. The kinetic characterization of the mutants is described; as well as the effect of substrate binding on the steady-state and time-resolved fluorescence signals. Finally, the possibility of using the recombinant Class II FBP aldolases for industrial chemical synthesis was explored by measuring the enzymatic stability in organic solvents, at high temperatures and at different pH conditions. Surprisingly, the commercial Class I enzyme from rabbit muscle was more stable than the metalloenzymes in most conditions tested. The results presented in this thesis will be useful for the future design of Class II FBP aldolase inhibitors.

Thesis--Helsinki. / Includes five papers on which the present dissertation is based (p. 61-131). Includes bibliographical references.

No description available.

No description available.

Résumé La prédominance de l'obésité qui touche les enfants et les adultes a augmenté dans le monde entier ces dernières décennies. Les différentes études épidémiologiques ont prouvé que l'obésité est devenue une préoccupation profonde de santé aux États-Unis et au Canada. Il a été montré que l'obésité a beaucoup d’effets sur la santé ainsi il serait important de trouver différentes causes pour le gain de poids. Il est clair que l'obésité soit la condition de multiples facteurs et implique des éléments génétiques et environnementaux. Nous nous concentrons sur les facteurs diététiques et particulièrement le fructose où sa consommation a parallèlement augmenté avec l'augmentation du taux d'obésité. La forme principale du fructose est le sirop de maïs à haute teneur en fructose (HFCS) qui est employé en tant qu'édulcorant primordial dans la plupart des boissons et nourritures en Amérique du Nord. Il a été suggéré que la prise du fructose serait probablement un facteur qui contribue à l’augmentation de la prédominance de l'obésité. L'objectif de cette étude était d'évaluer s'il y a un rapport entre la consommation du fructose et le risque d'obésité. Nous avons travaillé sur deux bases de données des nations Cree et Inuit. Nous avons eu un groupe de 522 adultes Cree, (263 femmes et 259 hommes) dans deux groupes d'âge : les personnes entre 20 et 40 ans, et les personnes de 40 à 60 ans. Nous les avons classés par catégorie en quatre groupes d'indice de masse corporelle (IMC). L'outil de collecte de données était un rappel de 24 heures. En revanche, pour la base de données d'Inuit nous avons eu 550 adultes (301 femmes et 249 hommes) dans deux groupes d'âge semblables à ceux du Cree et avec 3 catégories d’indice de masse corporelle. Les données dans la base d'Inuit ont été recueillies au moyen de deux rappels de 24 heures. Nous avons extrait la quantité de fructose par 100 grammes de nourriture consommés par ces deux populations et nous avons créé des données de composition en nourriture pour les deux. Nous avons pu également déterminer les sources principales du fructose pour ces populations. Aucun rapport entre la consommation du fructose et l’augmentation de l’indice de masse corporelle parmi les adultes de Cree et d'Inuit n’a été détecté. Nous avons considéré l’apport énergétique comme facteur confondant potentiel et après ajustement, nous avons constaté que l'indice de masse corporelle a été associé à l’apport énergétique total et non pas à la consommation du fructose. Puisque dans les études qui ont trouvé une association entre la consommation de fructose et l’obésité, le niveau de la consommation de fructose était supérieure à 50 grammes par jour et comme dans cette étude ce niveau était inférieur à cette limite (entre 20.6 et 45.4 g/jour), nous proposons que des effets negatifs du fructose sur la masse corporelle pourraient être testés dans des populations à plus haute consommation. Les essais cliniques randomisés et éventuelles études cohortes avec différents niveaux de consommation de fructose suivis à long terme pourraient aussi être utiles. Mots clés : fructose, sirop de maïs à haute teneur en fructose (HFCS), obésité et poids excessif / Summary The prevalence of obesity has increased worldwide in recent decades in both children and adults. Different epidemiologic studies have shown that obesity has become a serious health concern in United States and Canada. It has been proved that obesity has many adverse health outcomes so it is important to identify the different causes of weight gain. It is clear that obesity is a multifactor condition and involves both genetic and environmental elements. In this study, we focus on dietary factors, specifically the consumption of fructose that has increased in parallel to the increase in the obesity rate. The main form of fructose in the diet is high fructose corn syrup (HFCS) that is used principally as a sweetener in most beverages and foods in North America. It has been suggested that the intake of fructose may possibly be a contributing factor to the increased incidence of obesity. The objective of this study was to assess if there is a relationship between consumption of fructose and risk of obesity. We worked on two databases. The first database contained 24-hour recall data collected from a sample of 522 Cree adults (263 women and 259 men), divided into two age groups: people between 20 and 40 years old, and people from 40 to 60 years old. We categorized them into four body mass index (BMI) groups. The second database contained data from two 24-hour recalls administered to 550 Inuit adults (301 women and 249 men). These adults were divided into two age groups similar to Cree and with three BMI categories. The amount of fructose per 100 grams of food consumed by these two samples was calculated and we created food composition data for both. We also determined the main sources of fructose in these populations that was sugar sweetened beverages. Based on our results, we could not detect any relationship between consumption of fructose and an increase in BMI among Cree and Inuit adults. We considered energy intake as a potential cofounding factor and, after adjustment, we found that BMI was associated with total energy intake and not with the consumption of fructose. Since in studies that have found this association the level of fructose consumption was more than 50 grams per day but in this study, this level was lower than this limit ( from 20.6 to 45.4 g / day) , we suggest that negative effects of fructose on body weight may appear only at higher dose. Randomized clinical trials and prospective cohort studies using different levels of consumption with long term follow up could be useful. Key words: Fructose, High Fructose Corn Syrup (HFCS), Obesity, and Overweight

Dietary carbohydrate during pregnancy is essential but whether this requirement is specific to glucose or if fructose could substitute for glucose in the diet of pregnant rat dams was investigated. It was concluded that the carbohydrate requirement for the rat during pregnancy is not specific to glucose and the level, not the type, of carbohydrate was critical. The potential toxicity of high fructose diets was also investigated. Dams fed high fructose had significantly higher liver weights than dams fed high glucose while other toxic indicators were not affected. A third aspect was the comparison of isocaloric, low carbohydrate diets containing different sources of 4% glucose equivalents: glucose, fructose or lipid-glycerol. Fructose and lipid-glycerol were not adequate substitutes for glucose. The measurement of amniotic fluid glucose, which increased as either dietary glucose or fructose increased in the maternal diet may be a new, accessible nutritional indicator of carbohydrate status.